Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Messenger (Los Angeles, Calif. : Print)
|
May 23, 2017
Two-Pore Channels and Parkinson's Disease: Where's the Link?
Pilar Rivero-Ríos, Belén Fernández, Jesús Madero-Pérez, et al.
STAR Protocols
|
March 1, 2023
Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy
Elena Fdez, Rachel Fasiczka, Antonio Jesús Lara Ordóñez, et al.
Human Molecular Genetics
|
June 23, 2007
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
Berta Luzón-Toro, Elena Rubio de la Torre, Asunción Delgado, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
December 23, 2023
Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease
Krista K Alexander, Yahaira Naaldijk, Rachel Fasiczka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 11, 2005
Structural domains involved in the regulation of transmitter release by synapsins
Sabine Hilfiker, Fabio Benfenati, Frédéric Doussau, et al.
Frontiers in Molecular Neuroscience
|
November 29, 2018
RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
Jesús Madero-Pérez, Belén Fernández, Antonio Jesús Lara Ordóñez, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages
David Brough, Rosalind A Le Feuvre, Rachel D Wheeler, et al.
The Journal of Biological Chemistry
|
February 3, 2019
The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
Pilar Rivero-Ríos, María Romo-Lozano, Jesús Madero-Pérez, et al.
Human Molecular Genetics
|
December 4, 2008
Combined kinase inhibition modulates parkin inactivation
Elena Rubio de la Torre, Berta Luzón-Toro, Irene Forte-Lago, et al.
Biochemical Society Transactions
|
May 27, 2015
Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease
Pilar Rivero-Ríos, Patricia Gómez-Suaga, Belén Fernández, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Messenger (Los Angeles, Calif. : Print)
|
May 23, 2017
Two-Pore Channels and Parkinson's Disease: Where's the Link?
Pilar Rivero-Ríos, Belén Fernández, Jesús Madero-Pérez, et al.
STAR Protocols
|
March 1, 2023
Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy
Elena Fdez, Rachel Fasiczka, Antonio Jesús Lara Ordóñez, et al.
Human Molecular Genetics
|
June 23, 2007
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation
Berta Luzón-Toro, Elena Rubio de la Torre, Asunción Delgado, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
December 23, 2023
Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease
Krista K Alexander, Yahaira Naaldijk, Rachel Fasiczka, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 11, 2005
Structural domains involved in the regulation of transmitter release by synapsins
Sabine Hilfiker, Fabio Benfenati, Frédéric Doussau, et al.
Frontiers in Molecular Neuroscience
|
November 29, 2018
RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A
Jesús Madero-Pérez, Belén Fernández, Antonio Jesús Lara Ordóñez, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages
David Brough, Rosalind A Le Feuvre, Rachel D Wheeler, et al.
The Journal of Biological Chemistry
|
February 3, 2019
The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
Pilar Rivero-Ríos, María Romo-Lozano, Jesús Madero-Pérez, et al.
Human Molecular Genetics
|
December 4, 2008
Combined kinase inhibition modulates parkin inactivation
Elena Rubio de la Torre, Berta Luzón-Toro, Irene Forte-Lago, et al.
Biochemical Society Transactions
|
May 27, 2015
Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease
Pilar Rivero-Ríos, Patricia Gómez-Suaga, Belén Fernández, et al.
Page
of 6